BFA
GBT

BlackRock Fund Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

BlackRock Fund Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$14.6M Buy
1,010,270
+583,679
+137% +$10.3M ﹤0.01% 2359
2016
Q3 		$9.83M Buy
426,591
+93,926
+28% +$1.79M ﹤0.01% 2480
2016
Q2 		$5.52M Buy
332,665
+165,483
+99% +$3.34M ﹤0.01% 2739
2016
Q1 		$2.65M Sell
167,182
-3,939
-2% -$70K ﹤0.01% 2995
2015
Q4 		$5.53M Buy
171,121
+6,354
+4% +$275K ﹤0.01% 2787
2015
Q3 		$6.95M Buy
+164,767
New +$7.77M ﹤0.01% 2589

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return